title: Clinical improvement in antiphospholipid syndrome after rituximab therapy.
authors.affiliation: Lupus Research Unit, The Rayne Institute, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK. r.adamson.98@cantab.net
authors.forename: Rosemary
authors.initials: R
authors.lastname: Adamson
authors.forename: Shirish
authors.initials: S
authors.lastname: Sangle
authors.forename: Arvind
authors.initials: A
authors.lastname: Kaul
authors.forename: Graham R V
authors.initials: GR
authors.lastname: Hughes
authors.forename: David P
authors.initials: DP
authors.lastname: D'Cruz
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab